artenimol has been researched along with Endometrial Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, JC; Guo, X; Klausen, C; Leung, PCK; Li, Y; Li, Z; Xie, S; Yang, W; Zhang, Y; Zhou, J; Zhu, H; Zhu, Y | 1 |
| Tang, T; Xi, M; Xia, Q | 1 |
2 other study(ies) available for artenimol and Endometrial Neoplasms
| Article | Year |
|---|---|
Novel dihydroartemisinin dimer containing nitrogen atoms inhibits growth of endometrial cancer cells and may correlate with increasing intracellular peroxynitrite.
Topics: Animals; Artemisinins; Endometrial Neoplasms; Female; Humans; Nitrogen; PC12 Cells; Peroxynitrous Acid; Rats | 2019 |
Dihydroartemisinin and its anticancer activity against endometrial carcinoma and cervical cancer: involvement of apoptosis, autophagy and transferrin receptor.
Topics: Apoptosis; Artemisinins; Autophagy; Cell Line, Tumor; Endometrial Neoplasms; Female; Humans; Receptors, Transferrin; Uterine Cervical Neoplasms | 2021 |